Methysym (Methylphenidate Hydrochloride)

Methysym is a central nervous system stimulant indicated for the following conditions:

• Attention deficit hyperactivity disorder (children): improves focus, reduces hyperactivity and impulsivity.
• Attention deficit hyperactivity disorder (adults): enhances concentration and executive function.
• Narcolepsy: decreases excessive daytime sleepiness and improves wakefulness.

• Methylphenidate hydrochloride blocks the reuptake of dopamine and norepinephrine at neuronal synapses, increasing their extracellular concentrations. This heightened catecholaminergic activity enhances neurotransmission in brain regions responsible for attention, impulse control, and wakefulness, thereby mitigating the core symptoms of ADHD and narcolepsy.

Methylphenidate may cause a range of adverse reactions. Commonly reported events include:

Common Side Effects

• Insomnia: difficulty falling or staying asleep.
• Decreased appetite: reduced hunger leading to weight loss.
• Headache: mild to moderate cranial pain.
• Abdominal discomfort: stomach pain or nausea.
• Increased heart rate: mild tachycardia.
• Anxiety: heightened nervousness or restlessness.

Serious or Rare Side Effects

• Cardiovascular events: hypertension, arrhythmia, or myocardial infarction.
• Psychiatric symptoms: psychosis, mania, or severe agitation.
• Severe allergic reaction: rash, swelling, or anaphylaxis.
• Seizures: rare occurrence of convulsive episodes.
• Growth suppression: notable reduction in height or weight gain in children.

Before initiating therapy with Methysym, consider the following precautions:

• Cardiovascular assessment: evaluate history of heart disease, hypertension, or arrhythmias.
• Psychiatric monitoring: watch for new or worsening mood disorders, psychosis, or aggression.
• Growth monitoring: regularly assess height and weight in pediatric patients.
• Abuse potential: use only as prescribed due to risk of dependence.
• Pregnancy and lactation: discuss potential risks with a healthcare professional before use.
• Store at ambient temperature: keep in the original container, protect from moisture and heat.

Methylphenidate can interact with several medication classes. Review the following interaction categories:

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
• Sympathomimetic agents (e.g., ephedrine): may cause severe hypertension.

Moderate Interactions (Monitor Closely)

• Antidepressants (tricyclics, SSRIs): may increase plasma levels of methylphenidate.
• Antihypertensive drugs: potential reduction in blood pressure control.
• Antacids: may affect absorption and bioavailability.